Voriconazole use for endemic fungal infections
- PMID: 19139290
- PMCID: PMC2663067
- DOI: 10.1128/AAC.01148-07
Voriconazole use for endemic fungal infections
Abstract
In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.
References
-
- Al-Agha, O. M., M. Mooty, and A. Salarieh. 2006. A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Arch. Pathol. Lab. Med. 130:120-123. - PubMed
-
- Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, T. J. Walsh on behalf of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14. - PubMed
-
- Bakleh, M., A. J. Aksamit, I. M. Tleyjeh, and W. F. Marshall. 2005. Successful treatment of cerebral blastomycosis with voriconazole. Clin. Infect. Dis. 40:e69-e71. - PubMed
-
- Borgia, S. M., J. D. Fuller, A. Sarabia, and P. El-Helou. 2006. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med. Mycol. 44:659-664. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical